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C
ollagen type III glomerulopathy (CG), also
known as collagenofibrotic glomerulopathy, is
caused by accumulation of collagen type III in
glomeruli. Collagen type III is not a normal con-
stituent of the extracellular matrix of glomeruli, but
it is found in the interstitium and vessel walls.
Clinical features of CG include proteinuria (often in
the nephrotic range), edema, and hypertension.1,2
The condition can progress to end-stage kidney
disease, requiring dialysis or renal transplantation.
While initial reports of CG were largely in patients
of Asian descent, subsequent cases in patients of
European descent were published.1,3–7 Approxi-
mately 100 cases have been reported in the literature
(Supplementary Table S1). We report the first case of
CG in an African American patient, suggesting that
the condition may be an unrecognized cause of
proteinuria in patients of African American descent.
Furthermore, our case, as well as 2 of the earliest
reported cases,3,8 documents CG in a female who
presented with a history of proteinuria associated
with pregnancy, highlighting the need to include CG
in the differential of female patients who develop
new-onset or worsening proteinuria and hyperten-
sion with pregnancy. This rare disease has over-
lapping clinical features with many conditions that
can produce nephrotic-range proteinuria, leading to
a clinical diagnostic dilemma (Table 1). Likewise, the
histologic pattern can be confused with conditions
that cause a nodular or membranoproliferative
glomerular change, such as amyloidosis and/or
fibrillary glomerulonephritis, diabetic nephropathy,
fibronectin glomerulopathy, light chain deposition
disease, and thrombotic microangiopathy, as well as
other conditions with collagen deposition, such ashereditary multiple exostoses and nail–patella syn-
drome (NPS).CASE PRESENTATION
Clinical History and Laboratory Data
A 42-year-old African American woman with a
medical history significant for hypertension was
recently diagnosed with type 2 diabetes and obesity.
She was originally diagnosed with proteinuria 18
years earlier, during her first pregnancy, with 2
subsequent pregnancies each complicated by pro-
teinuria. The proteinuria resolved after delivery in
the first 2 instances; however, she remained protei-
nuric after her third pregnancy and had been
maintained on an angiotensin-converting enzyme in-
hibitor. Two years before the current presentation,
she had a possible transient ischemic attack (TIA) in
the setting of suboptimal blood pressure control and
had a second TIA almost 2 years later, after which
additional antihypertensive treatment was added. On
a regular follow-up visit, she was found to be
persistently proteinuric with 10 g in a 24-hour urine
collection. Remaining laboratory results included
creatinine 1.2 mg/dl, serum albumin 3.1 g/dl, and
Hgb 9.8 g/dl with a low mean corpuscular volume
(69 fl). Hemoglobin A1c was 6.4%. Her blood pres-
sure was adequately controlled.
She had no constitutional symptoms and her phys-
ical examination was unremarkable except for lower
extremity edema. There was no family history of renal
disease. Her medications included aspirin, statin, dil-
tiazem, hydralazine, hydrochlorothiazide, Lisinopril,
metoprolol, empaglifozin, liraglutide, iron and calcium
supplements, loratadine, and fluticasone spray.
A kidney biopsy specimen was obtained.Kidney International Reports (2021) 6, 1738–1742
Table 1. Teaching points
Collagen type III glomerulopathy (CG) is a rare condition and can present with signs and
symptoms such as nephrotic-range proteinuria and mild hematuria that evoke a broad
clinical differential diagnosis
The typical patient with CG is Asian, though the condition should be considered in patients
of European and African descent as well
A pregnant patient with proteinuria and hypertension is most often assumed to have
pre-eclampsia; however, other conditions should also be considered in the
differential diagnosis, particularly if pre-existing proteinuria worsens during pregnancy
The diagnosis of CG depends on electron microscopy demonstrating atypical collagen
fibrils in the subendothelial space and mesangium; contrarily, nail–patella syndrome is
characterized by collagen fibrils within the glomerular basement membrane
Immunohistochemistry for collagen type III can be useful for confirmation of the
diagnosis of CG
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Light microscopy showed approximately 30 glomeruli, of
which 2 were globally sclerosed and 3 had segmental
sclerosis. All patent glomeruli were characterized by a
distinct global to near-global eosinophilic expansion of
the mesangium and capillary walls, imparting a lobulated
appearance with reduced overall cellularity (Figure 1a).
Capillary walls had segmental duplication of the basement
membranes and silver stain showed an unusual pattern of
membrane staining with a normal outer layer, central
clearing, and an inner complex layer (Figure 1b). There
was indistinct staining of the mesangial regions. Much of
the expanded subendothelial and mesangial areas were
also negative on periodic acid–Schiff (PAS) stain
(Figure 1c). The tubulointerstitium showed mild focal
tubular atrophy and interstitial fibrosis in approximately
20% of the cortical sample with focal lymphocytic
inflammation in the small areas of scarring. The small
arteries sampled were unremarkable and the arterioles
had moderate hyaline thickening. Immunofluorescence
microscopy was negative for all immune reactants. Elec-
tron microscopy revealed marked subendothelial and
mesangial accumulation of collagen fibers (Figure 2a and
b), sometimes curved or frayed, some arranged in irreg-
ular bundles (Figure 2c), and many showing banding
with periodicity that averaged 54.5 nm (Figure 2d). The
fibrils were present in the expanded subendothelial space
and not within the glomerular basement membrane. The
fibers were less delicate than collagen fibers normally
seen in the renal interstitium and sometimes found in the
glomeruli in other sclerosing conditions. The fibers were
much larger than those seen in amyloid or fibrillary
glomerulonephritis. They also differed in appearance
from the enhanced matrix proteins seen in nodular dia-
betic glomerulosclerosis, i.e., fibrillosis, in which the fi-
brils are smaller and less haphazardly arranged. There
was also diffuse podocyte foot process effacement.
Additional Studies
Collagen type III immunohistochemistry was per-
formed on formalin-fixed, paraffin-embedded tissue
sections with antibody to collagen type III (BioGenex,Kidney International Reports (2021) 6, 1738–1742San Ramon, CA; monoclonal clone HWD1.1; 1:80) using
a Leica BOND-III automated stainer as previously
described.9 Immunohistochemistry demonstrated the
expected internal control staining of the interstitium
and showed prominent staining of expanded glomer-
ular mesangium and capillary walls (Figure 1d).
We also searched the kidney biopsy archives of the
Johns Hopkins Department of Pathology for cases of CG
(institutional review board–approved study 00090103).
From 1994 to 2018, there were 33,137 biopsies proced-
ures performed. Searching for the term glomerulopathy
(3999 cases) with subsequent searches of these cases
using the terms collagen (106 cases) and type (62 cases)
identified 1 case diagnosed as probable CG and 2 cases
diagnosed as possible CG. Five other cases mentioned
increased collagen fibers in the biopsy specimen report
but were considered unlikely to be CG at the time of
biopsy based on histologic features together with the
clinical information. These 8 cases were reviewed and
collagen type III immunohistochemistry was performed
on the 3 cases considered possible or probable. None of
these additional cases showed positive staining.
Clinical Follow-Up
The patient was diagnosed with alpha-thalassemia and
as part of serologic work-up, was found to have posi-
tive antinuclear antibodies and SS-A. The patient’s
renal function is preserved, her proteinuria is stabi-
lized, and her hypertension is under control.
DISCUSSION
Collagenofibrotic glomerulopathy is a rare condition
caused by mesangial and subendothelial deposition of
collagen type III in glomeruli. Collagen type III is a normal
matrix protein found in the interstitium and vessels of
most tissues, but it is not normally present in the
glomerulus. Because of this atypical deposition of
collagen type III, the disorder is also referred to as CG.
Initially, CG was thought to be a subset of the genetic
disorder NPS, also known as hereditary osteo-
onychodysplasia. NPS is an autosomal dominant condi-
tion caused by a mutation in LMX1B transcription factor
and usually presents during childhoodS1; CG may have a
genetic basis in some affected individuals, particularly
when presenting in childhood, as suggested by several
sibling pairswith CG,6,8,S2,S3 but inmany cases there is no
evidence of familial or genetic correlation and it is
considered a sporadic disorder when manifesting in
adulthood. NPS is a pleiotropic disorder with symptoms
ranging from maldeveloped nails and kneecaps to glau-
coma, and can involve the skin and kidneys, with renal
effects that mimic the symptoms present in CG.S1 How-
ever, in NPS, nephrotic symptoms are not noted in the
absence of skeletal abnormalities, and the disease course1739
Figure 1. (a) Glomeruli show eosinophilic expansion of mesangium and capillary walls without increased cellularity. Hematoxylin and eosin stain;
original magnification 200. (b) Nonargyrophilic expansion of mesangium and capillary walls with segmental double contour formation. Periodic acid–
Schiff (PAS) methenamine silver stain; original magnification 400. (c) PAS-negative mesangial and capillary wall expansion. PAS stain; original
magnification 400. (d) Collagen type III in glomeruli and interstitium. Immunohistochemical stain for collagen type III; original magnification 200.
NEPHROLOGY ROUNDS ALV Wilson et al.: Collagen Type III Glomerulopathydoes not always lead to kidney failure. In CG, skeletal and
cutaneous abnormalities are not present, though rare
cases of extrarenal organ involvement have been repor-
ted.S4,S5 Patients with CG typically present with pro-
teinuria (often in the nephrotic range), edema,
hypertension, variable hematuria, and usually mild
impairment of renal function. These features overlapwithFigure 2. (a) Markedly expanded mesangium and capillary walls. Scale b
capillary wall (asterisks). Scale bar ¼ 5 mm. (c) Expanded areas contain b
with periodicity of 54.5 nm, focal fraying, and a haphazard arrangement.
1740a wide variety of disorders affecting the kidney, leading
to a broad clinical differential diagnosis. The disease
course of CGultimately leads to renal failure, oftenwithin
10 years,S6,S7 with some patients, particularly younger
patients, experiencing a more rapid decline.6,S8
The initial cases of CG were described in Japanese
patients in the late 1970s; Arakawa et al.3 presented thear ¼ 20 mm. (b) Expanded mesangium and subendothelial aspect of
undles of thick fibrils. Scale bar ¼ 2 mm. (d) Fibrils contain banding
Scale bar ¼ 500 nm.
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specimens with a peculiar glomerulopathy described as
mesangio-degenerative. One case was a 34-year-old
woman who had proteinuria since 23 years of age and
developed increased proteinuria and hypertension during
2 pregnancies, and a 65-year-old man with nonnephrotic
proteinuria and hypertension. Biopsy specimens from
both cases demonstrated collagen fiber collections in the
mesangium and subendothelial space. In 1982, Dombros
and Katz4 described a case with morphologic features
similar to NPS but without skeletal abnormalities in a 34-
year-old white woman. Ikeda et al.5 identified the fibers
as type III collagen and referred to the condition as pri-
mary glomerular fibrosis. Those cases were followed
over the next several decades by cases documented in
France,6 China,S2,S9 Japan,S4,S10–S12 India,2,S13–S16 Italy,1
Argentina,S17 Brazil,S18 Saudi Arabia,S8 and the United
States.7,S19 A case of CG was reported in a Croatian man in
Australia in 2018.S20 To our knowledge, there are no re-
ported cases of CG in an African American patient.
A diagnosis of CG requires a renal biopsy and relies
heavily on the ultrastructural finding of characteristic
extracellular collagen accumulation in the mesangium
and along the capillary walls of the glomeruli. The
presence of collagen III is not abnormal in the kidney;
the human kidney normally has collagen III present in
the interstitium and blood vessel walls, but collagen III
is not normally present in the glomeruli. On electron
microscopy, the collagen fibers can be localized and
segmental or extensively deposited throughout the
glomerulus, in the mesangium and in the subendothelial
aspect of the capillary wall. The collagen often has an
unusual appearance, being thicker than typical collagen
fibers, forming curved bundles, and showing frayed
ends. In CG, collagen III deposition is distinct from NPS
by its presence within the glomerular basement mem-
brane in NPS, while in CG the collagen is found in the
subendothelial aspect of the capillary wall. In NPS, the
collagen deposition is usually difficult to discern using
standard techniques for EM and often requires treat-
ment with phosphotungstic acid.
On light microscopy the changes are variable; at least
2 patterns have been reported, with features on hema-
toxylin and eosin that could be mistaken for amyloid,
thrombotic microangiopathy (TMA), or the nodular
Kimmelstiel–Wilson lesions of diabetes. As in our case,
most have striking pale eosinophilic capillary walls and
mesangial expansion. Others have less severe capillary
wall thickening with double contour formation evident
on special stains and mild mesangial expansion. Some
cases show a more distinct but usually mild mesangial
expansion with minimal capillary wall thickening. The
areas of expansion are characteristically PAS- and silver-
negative. There is no apparent correlation of clinicalKidney International Reports (2021) 6, 1738–1742features with any of the patterns; however, the pattern
noted in our case, with massive deposition of collagen,
may indicate more chronic or advanced forms of the
disease in adults. Regardless of the pattern on light
microscopy, immunofluorescence studies show minimal
if any immune deposition, usually immunoglobulin M
and/or C3, believed to be nonspecific. Immunohisto-
chemistry with antibody for collagen III can be used to
confirm the diagnosis if electron microscopy is not
available or as an adjunct to electron microscopy; Congo
red and special stains such as PAS and silver can assist in
excluding amyloid, diabetes, or TMA.
The pathogenesis of the abnormal type III collagen
deposition in the kidney is unclear, though it is associated
with greatly increased levels of serum procollagen type
III peptide (PIIINP).5 Elevated PIIINP can also be associ-
ated with other conditions that result in fibrosis and is
not a specific indicator of CG,S21 although the levels
found in patients with CG are typically much higher than
in patients with other fibrosing conditions.5,S5
Whether CG is a primary renal disease process or a
manifestation of a systemic disease is also not known.
Collagen fibers, even collagen type III, can be seen in
glomeruli in some chronic glomerular diseases, though
usually in small amounts; what causes the massive accu-
mulation seen in CG is not known. Naruse et al.S22 found
that mesangial cells in patients with CG expressed alpha-
smooth muscle actin and proposed that myofibroblastic
transformation of the cells occurred, allowing them to
synthesize type III collagen. Kreisberg and Karnovsky S23
showed that mesangial cells in culture can produce types
I, III, and IV collagen, and Scheinman et al.S24 found that
mesangial cells have messenger RNA signal for procolla-
gen alpha 1 (III), though isolated cells could have un-
dergone transformation in culture leading to expression of
interstitial-type collagen. Alchi et al.S7 noted that
interleukin-4 stimulates type III collagen synthesis by
mesangial cells. Thus, mesangial cells could be responsible
for the accumulation of collagen III caused by glomerular
injury and/or cytokine stimulation. The increase in syn-
thesis of type III collagen could explain the increased
serum levels of PIIINP. Serum levels of procollagen type
III peptide as well as hyaluronan are elevated in patients
with CG, with a reduction in both serum hyaluronan
levels and symptoms of CG after a kidney transplant,
which supports an intrarenal origin for the collagen III.S12
Vogt et al.7 documented an association between
inherited factor H deficiency and CG. It has been noted in
isolated cases of hemolytic uremic syndrome and may
contribute to glomerular endothelial injury from
complement-mediated damage and thus could allow
abnormal access by collagen III to the subendothelial
compartment. A frequent finding of anemia in patients
with CG may suggest a similar pathogenesis to thrombotic1741
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microscopy. Abnormally high serum levels of PIIINP
along with the fact some CG patients show substantial
deposition of abnormal collagen fibers in organs other
than the kidney suggests a systemic cause is possible or at
least may contribute to the development of CG.S7
In terms of clinical outcomes, NPS does not always
lead to renal failure, whereas CG often progresses to
end-stage renal disease.1,5,6,S5 Treatment is generally
supportive and is focused on addressing proteinuria,
edema, and hypertension with the use of angiotensin-
converting enzyme therapy.S9 Steroids have been
used in some cases with at least temporary improve-
ment.S6 Although kidney transplant is not the first line
of treatment for CG, in the few cases where patients
received kidney transplants there has been no recur-
rence of CG symptoms or pathology.S7,S25
Patients with CG all have some variation of presenting
signs and symptoms that include proteinuria, hyperten-
sion, and edema. These features overlap with those of
pre-eclampsia. Our patient as well as one of Arakawa
et al.’s initial cases of CG3 were both noted to have pro-
teinuria before pregnancy that increased during preg-
nancy, with a renal biopsy specimen obtained because of
the persistence of proteinuria after delivery. Tamura
et al.8 also described a patient who developed proteinuria
during pregnancy, with temporary resolution of pro-
teinuria after delivery, who was later diagnosed with CG.
The pathophysiology of a CG-related increase in pro-
teinuria with pregnancy may stem from the increased
perfusion pressure that occurs during pregnancy in the
setting of an already compromised filtration barrier
because of the presence of abnormal collagen along the
capillary wall. Alternatively, changes in the endo-
thelial layer during pregnancy and in conditions with
microangiopathic injury could allow accumulation of
collagen in the subendothelium that would not
otherwise be possible. This theory seems less likely
given the presence in males, children, and other
adults without hemolytic uremic syndrome or TMA,
and the persistence of the collagen many years after
pregnancy. In addition, the relatively common
occurrence of microangiopathies compared with the
rare incidence of CG suggests that other mechanisms
are at least in part responsible for the accumulation of
collagen type III in the glomerulus.
CONCLUSION
In summary, CG is a diagnosis that should be consid-
ered in a patient of African ancestry with proteinuria,1742though most cases reported are in individuals of Asian
or Western European descent. Further, this study
highlights the necessity of broadening the differential
diagnosis of the pregnant female patient who develops
proteinuria during pregnancy or has an increase of pre-
existing proteinuria while pregnant.
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